<DOC>
	<DOCNO>NCT03094806</DOCNO>
	<brief_summary>This study evaluate use respiratory device , Acapella Vibratory Positive Expiratory Pressure ( PEP ) Therapy device , patient admit hospital chronic obstructive pulmonary disease ( COPD ) exacerbation .</brief_summary>
	<brief_title>Vibratory PEP Device Hospital Length Stay Acute Exacerbation COPD</brief_title>
	<detailed_description>The investigator hypothesize PEP-FV use adjunctive therapy patient hospitalize acute exacerbation COPD result decrease hospital length stay improvement overall COPD-related health outcome .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Admitted COPD exacerbation primary diagnosis Subjectively produce 1 tablespoon ( 15 ml ) / day sputum Has subjective feeling he/she cough clear secretion Physical respiratory system exam physician evidence course ronchi suggestive impacted secretion &gt; 10 packyear smoke history Can use flutter device unable follow command Altered mental status Known active malignancy Known systolic CHF EF &lt; 40 % clinically acute CHF exacerbation document cardiologist primary diagnosis COPD Pregnancy Patients severe exacerbation ( Intubated , Continuous use NIPPV , Unable speak full sentence ) Intracranial pressure ( ICP ) &gt; 20 mmHg Hemodynamic instability ( require vasopressor support ) Recent facial , oral , skull surgery trauma . Acute sinusitis . Epistaxis . Esophageal surgery . Active Hemoptysis ( More 2 tablespoon frank blood per day ) Nausea . Severe earache discharge ear . ( Known suspect tympanic membrane rupture middle ear pathology ) Untreated pneumothorax .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>